Skip to main content

Congratulations to Epidemiology PhD students, Kathryn Hatchell and Jung-Im Shin

Kathryn Hatchell (left) and Jung-Im Shin (right)

Congratulations to Population Health Sciences Epidemiology PhD students Kathryn Hatchell and Jung-Im Shin on securing positions at leading institutions!

Kathryn Hatchell
Kathryn, a current PhD student in the Population Health Sciences Department, has been offered and accepted a Project Manager- Genomics & Informatics position, with Geisinger National - Precision Health, a new Washington DC based initiative within the Geisinger Health System. In her role, Kathryn will join the Precision Health Innovation Lab and will research links between genetics and health outcomes and integrate this knowledge into the stream of healthcare.

Geisinger Health System is one of the nation’s most innovative health services organizations, Geisinger serves more than 1.5 million patients in Pennsylvania and New Jersey. The system includes 13 hospital campuses, a nearly 600,000-member health plan, two research centers and the Geisinger Commonwealth School of Medicine. Geisinger is known for its focus on caring and innovative programs, including Geisinger’s MyCode® Community Health Initiative, the largest healthcare system-based precision health project in the world. With more than 215,000 volunteer participants enrolled, MyCode is conducting extensive research and returning medically actionable results to participants. Repeatedly recognized nationally for integration, quality and service, Geisinger has a long-standing commitment to patient care, medical education, research and community service.

Geisinger National Precision Health is a new Geisinger Health System initiative, based in the Washington, D.C., area, that leverages the Geisinger model of integrating genomics and data science into precision healthcare, while building new strategic partnerships and ventures to extend the Geisinger model on the national scene. This program will utilize the extensive advances of the MyCode Community Health Initiative and electronic health data integration at Geisinger.

For more information, click here


Jung-Im Shin
Jung-Im Shin is an Assistant Scientist in the Department of Epidemiology at the Johns Hopkins Bloomberg School of Public Health and an Associate Faculty member of the Welch Center for Prevention, Epidemiology and Clinical Research, a large interdisciplinary research unit that bridges the Schools of Medicine and Public Health. She was hired by the Department immediately upon completion of her post-doctoral fellowship at Johns Hopkins in 2018. Her research area of interest lies at the interface of diabetes, cardiovascular disease, and chronic kidney disease with an emphasis on pharmacoepidemiology to improve the safe and effective use of medications.

Before her path to a research career in epidemiology, Jung-Im received clinical training in Internal Medicine and Cardiology in South Korea, and worked as a clinician in Cambodia and Uganda.

During her PhD training in the Department of Population Health Sciences, at the UW-Madison, she learned a broad array of epidemiologic methods covering study design, measurement, and analysis. With the guidance of Dr. Brad Astor, she was able to apply her didactic training to various research projects and found pharmacoepidemiology to be a particularly fascinating research area in which to apply her quantitative skills to address research questions driven by clinical experience.

Following her PhD, Jung-Im received T32-funded post-doctoral training at Johns Hopkins to gain additional skills for the analysis of “big” administrative healthcare data and methodological standards in pharmacoepidemiology.

Her career goal is to become an experienced researcher with expertise in pharmacoepidemiology and quantitative methods within research areas of cardiovascular and kidney disease. As a faculty member at Johns Hopkins, she will be able to achieve this by collaborating with other experts and leading independent investigations utilizing novel analytical approaches in pharmacoepidemiology.

Dr. Shin would like to express her gratitude to her PhD advisor, Dr. Brad Astor and the Department of Population Health Sciences for their gracious support.